Psychedelics – News and Features

News
Pharmaceutical Profiles Delivers Critical ivPK Data in Early Drug Development
The new protocol exploits the company’s know-how and capabilities in development and manufacture of iv dosage forms and their efficient integration into clinical studies.

News
Aspire IRB, Independent Review Board is Breaking new Ground Overseeing Clinical Research Trials
The Company has announced record growth, new medical director and pediatric board member.

News
MicroDose Technologies Announces Achievement of Phase I Clinical Milestone under Collaboration with Merck
The milestone signals the initiation by Merck of a Phase I clinical study of an investigational compound using the MicroDose DPI technology.

News
New Data Further Strengthens Case for Microdosing in Drug Development
The EUMAPP consortium presented preliminary results from the 30-month, €2m project at the EUFEPS Conference.

News
Scientists in Spain Develop New Methods for Monitoring Drug Abuse by Analyzing Wastewater
Applied Biosystems/MDS Analytical Technologies technology helps provide new insights into consumption of illegal drugs.

News
Dymension 2D Gel Analysis Software used at Specialist Institute
Syngene’s software is being used to identify proteins induced by an anti-addictive compound.

News
Vitalea Science Partners with SGS Life Science Services to Provide Microdosing Studies
The partnership further strengthens the complementary services offered by both SGS and Vitalea in executing early clinical trials based on the exploratory-IND concept.

News
Xceleron and Organon Sign Microdose Study Agreement
Xceleron announce collaboration with Organon on a three-compound human microdose study focusing on candidate selection for further clinical development.

News
Corcept Therapeutics and Xceleron Sign Agreement for Microdosing Study Using Accelerator Mass Spectrometry
The agreement aims at a human microdosing study of one of Corcept’s new chemical entities utilizing Xceleron’s AMS technology.

News
Vitalea Science Completes Dermal Distribution Microdose Study
Vitalea has completed a microdosing study assessing properties of a nutrient compound essential to prostate health and prevention of cellular oxidative damage.
Advertisement